PHARMACORP RX INC (PCRX.CA) Stock Income Statement
Canada - TSX Venture Exchange - TSX-V:PCRX - CA71714X1050 - Common Stock
0.415 CAD
+0.01 (+3.75%)
| TTM (2025-9-30) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 17.60M | 5.79M | 0.00 | 0.00 | 0.00 | |||
| Minority Interest Expense | 7.10K | 38.10K | N/A | N/A | N/A | |||
| Cost Of Goods | 10.60M | 3.61M | N/A | N/A | N/A | |||
| Gross Profit | 7.00M | 2.18M | N/A | N/A | N/A | |||
| Operating Expenses | 7.24M | 3.77M | 578.00K | 563.20K | 26.50K | |||
| Selling, General, and Administrative Expenses | 6.45M | 3.48M | 578.00K | 563.20K | 26.50K | |||
| Operating Income | -243.10K | -1.59M | -578.00K | -563.20K | -26.50K | |||
| Interest Income/Expense | 374.30K | 348.80K | 107.50K | 46.10K | 700.00 | |||
| Other Income/Expense | 191.20K | 82.10K | N/A | N/A | N/A | |||
| Income Before Taxes | 322.30K | -1.16M | -470.40K | -517.10K | -25.80K | |||
| Income Tax | 139.80K | -106.50K | N/A | N/A | N/A | |||
| Net Income | 189.60K | -1.01M | -470.40K | -517.10K | -25.80K | |||
| EBITDA | 546.90K | -1.30M | N/A | N/A | N/A | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | 0.00 | -0.01 | -0.01 | -0.02 | -0.00 | |||
| Statistics | ||||||||
| Gross Profit Margin | 39.77% | 37.70% | N/A | N/A | N/A | |||
| Profit Margin | 1.08% | -17.48% | N/A | N/A | N/A | |||
| Operating Profit Margin | -1.38% | -27.41% | N/A | N/A | N/A | |||
All data in CAD